I
Ian D. Pavord
Researcher at University of Oxford
Publications - 654
Citations - 55329
Ian D. Pavord is an academic researcher from University of Oxford. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 108, co-authored 575 publications receiving 47691 citations. Previous affiliations of Ian D. Pavord include John Radcliffe Hospital & University of Warwick.
Papers
More filters
Journal Article
Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
Sally E. Wenzel,Ian D. Pavord,Bingzhi Zhang,Jaman Maroni,Paul Rowe,J. D. Hamilton,Brian N. Swanson,Nikhil Amin,Gianluca Pirozzi,Neil M.H. Graham,Ariel Teper +10 more
Journal ArticleDOI
Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study
Juliet M. Foster,Richard Beasley,Irene Braithwaite,Tim Harrison,Mark Holliday,Ian D. Pavord,Helen K. Reddel +6 more
TL;DR: The as-needed budesonide-formoterol regimen was preferred to maintenance ICS treatment in mild asthma though patient education is urgently needed to address implementation motivation.
Journal ArticleDOI
Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST.
Jorge Maspero,JM FitzGerald,Ian D. Pavord,Megan S. Rice,Jaman Maroni,Paul Rowe,Gianluca Pirozzi,Nikhil Amin,Marcella Ruddy,Neil M.H. Graham,Ariel Teper,Megan Hardin +11 more
TL;DR: Dupilumab significantly improved lung function and exacerbation rates in adults, as previously observed in the overall QUEST population and in the adolescent population, results should be interpreted within the context of these limitations.
Journal ArticleDOI
Asthma control, airway responsiveness and airway inflammation.
TL;DR: In a cross-sectional study of 134 patients attending a local asthma clinic, the authors assessed the relationship between the ACQ score, methacholine airway responsiveness and eosinophilic airway inflammation assessed using induced sputum and exhaled nitric oxide concentration (FENO).
Journal Article
Effect Of Qaw039, An Oral Prostaglandin D2 Receptor (dp2/crth2) Antagonist, Upon Sputum And Bronchial Eosinophilic Inflammation And Clinical Outcomes In Treatment-Resistant Asthma: A Phase 2a Randomized Placebo-Controlled Trial
Rachid Berair,Sherif Gonem,Amisha Singapuri,Ruth Hartley,M Laurencin,Gerald Bacher,Bjoern Holzhauer,Michelle Bourne,Vijay Mistry,Ian D. Pavord,Adel H. Mansur,Andrew J. Wardlaw,Salman Siddiqui,Richard Kay,C E Brightling +14 more